# BORIC ACID

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid101014603
Categories: industrial, pharma
Functions: Biocide, Flame retardant, Stabilizing agent, pH regulating agent
Identifier: DTXSID101014603

> BORIC ACID is used as biocide / flame retardant. EPA CPDat observed this chemical in 7 composition records across product categories including Raw materials. Assessed from 21 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 7 composition records across product categories including Raw materials.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 7 composition records across product categories including Raw materials. EPA CPDat classifies this chemical for functional uses including pH regulating agent, Biocide, Stabilizing agent.
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.05 %w/w
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.6 %w/v
- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 3 mg
- US: inactive ingredient database — Route: BUCCAL; Dosage form: MOUTHWASH; Potency: 7.36 mg/1ml
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 0.53 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 210 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: DROPS; Potency: 1 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: EMULSION; Potency: 0.3 %w/v
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: GEL; Potency: 0.5 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 60 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION, GEL FORMING, EXTENDED RELEASE; Potency: 0.3 %w/w
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 48 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION; Maximum daily exposure: 12 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 22 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: EMULSION; Potency: 1.3 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SHAMPOO; Potency: 2 %w/w
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SUSPENSION/ DROPS; Potency: 0.3 %w/v
- US: inactive ingredient database — Route: VAGINAL; Dosage form: JELLY; Potency: 1 %w/w
- US: marketed drug occurrence — FDA NDC lists this ingredient in 13 active drug products and 15 total products.

_Assessed by Greenveil._